- Business
- Calvert Equity Fund (CSIEX) is an open-end mutual fund that seeks growth of capital through investments primarily in common stocks of large-cap U.S. companies believed to offer potential for capital appreciation; it applies a fundamental, bottom-up research approach guided by Calvert's Principles for Responsible Investment, emphasizing issuers that demonstrate strong earnings growth, cash flow, returns on capital, and alignment with environmental, social, and governance (ESG) criteria including equitable societies, human rights, diversity, and sustainability. The fund normally invests at least 80% of its net assets in equity securities of large-cap companies, defined as those ranking among the top 1,000 by market capitalization, with a portfolio typically comprising 50 holdings concentrated in top sectors such as technology (approx. 23%), financial services (22%), healthcare (17%), and industrials (10%); top holdings as of mid-2025 include Danaher Corp, Mastercard Inc, Visa Inc, Alphabet Inc Class C, and Microsoft Corp, representing over 23% of assets. It offers multiple share classes including Class A (CSIEX) with a front-end load of 5.25%, minimum initial investment of $1,000, adjusted expense ratio of 0.90%, and low portfolio turnover of 9%; the fund may also allocate to mid-cap stocks, publicly traded REITs, foreign stocks via ADRs or GDRs, securities lending, and a small Special Equities program for high social impact investments. Established in 1987 and managed by Calvert Research and Management, a leader in responsible investing founded in 1976 and headquartered at 1825 Connecticut Avenue NW, Suite 400, Washington, DC, the firm was acquired by Eaton Vance in 2017 and now operates as part of Morgan Stanley Investment Management following Morgan Stanley's 2021 acquisition of Eaton Vance; assets under management for CSIEX stand at approximately $5.9 billion as of mid-2025. In recent developments, Calvert Research and Management maintained a consistent principles-based proxy voting approach during the 2025 season amid shifting landscapes, expanded U.S. ESG equity offerings with new mutual funds launched in 2023, announced a $25,000 contribution from Morgan Stanley Investment Management in July 2024 to support initiatives, and continued emphasis on circular economy opportunities and materiality-focused ESG research as highlighted in late 2025 insights. The fund targets long-term investors seeking large-growth exposure with ESG integration, primarily U.S.-focused operations though permissible in foreign securities, and remains an attractive option for patient holders despite its atypical responsible investment style.